Skip to content

DASH Diet, Quality of Life and Cardiac Parameters of Patients With Acute Coronary Syndrome

The Effect of the DASH (Dietary Approaches to Stop Hypertension) Diet on Quality of Life and Cardiac Parameters in Patients Acute Coronary Syndrome With Hypertension

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06485765
Enrollment
34
Registered
2024-07-03
Start date
2020-06-01
Completion date
2021-09-01
Last updated
2024-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome, Hypertension

Keywords

acute coronary syndrome, hypertension, DASH diet, quality of life, cardiac parameters

Brief summary

The clinical trail study aimed to determine effect of DASH eating plan on cardiac parameters and quality of life in hypertensive individuals diagnosed with acute coronary syndrome. The main questions it aims to answer are: 1. DASH diet improve quality of life? 2. DASH diet improve cardiac parameters? The researchers assessed the results of 12 weeks of the DASH diet. Patients will apply the DASH diet prepared individually by the researchers for 12 weeks.

Detailed description

The study period was 12 weeks. Patients' food consumption (3 day), anthropometric measurements, blood pressure measurements, physical activity levels, biochemical and cardiac parameters, adherence to DASH eating plan and the MacNew Heart Health-Related Quality of Life Scale were recorded at the beginning of the study and at the end of 12 weeks.

Interventions

OTHERDiet planning

Healthy eating planning

Sponsors

Bandırma Onyedi Eylül University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

This clinical trial is a single-group, pre-post design. In this model, quality of life and cardiac parameters were assessed before and after individualised DASH diet.

Eligibility

Sex/Gender
ALL
Age
19 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* diagnosed with acute coronary syndrome within the last month * with a measured blood pressure above 140/90 mmHg or using antihypertensive drugs * not obese (body mass index \< 30) * not diagnosed with a disease requiring a different medical nutrition therapy (chronic renal failure, diabetes, cancer, etc.) * volunteered to participate in the study

Exclusion criteria

* Acute coronary syndrome diagnosed more than 1 month ago * obese (body mass index \> 30 ) * without hypertension * receiving different medical nutrition therapy

Design outcomes

Primary

MeasureTime frameDescription
Quality of Life (MacNew Heart Disease Health-Related Quality of Life Scale)12 weekThe quality of life of the patients at the beginning of the study and at the end of the 12th week was assessed with the MacNew Heart Disease Health-Related Quality of Life Scale. The scale is a different form of the Post-MI Quality of Life Scale, which was developed to determine especially depression and anxiety in patients with acute MI (Myocardial Infarction) and which can be evaluated by patients responding to the scale. The scale can be used in different cardiac patients such as MI, angina pectoris and heart failure patients and there is a high correlation between it and other tools that assess quality of life. MacNew Heart Disease Health-Related Quality of Life Scale consists of three sub-dimensions (emotional, physical and social) and 27 items in 7-point Likert type. The answer to each item is between 1-7. A low score indicates poor quality of life, while a high score indicates better quality of life.
Ejection Fraction (%)12 weeksA measurement of the percentage of blood leaving the heart each time it squeezes (using echocardiographic imaging)

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026